Division of Hematology

217(top 1%)

papers

6.3K(top 1%)

citations

42(top 1%)

h-index

75(top 1%)

g-index

223

all documents

6.6K

doc citations

1.2K

citing journals

Top Articles

#	Title	Journal	Year	Citations
1	Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia	American Journal of Medicine	2004	415
2	Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients	Annals of Oncology	2010	386
3	A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications	Leukemia	2010	321
4	Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients	Haematologica	2008	241
5	Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference	Blood	2009	229
6	Splenic marginal zone lymphoma: a prognostic model for clinical use	Blood	2006	217
7	WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)	Blood	2008	192
8	Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome	Blood	2011	173
9	Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis	Blood	2010	153
10	Deletions of the transcription factor Ikaros in myeloproliferative neoplasms	Leukemia	2010	135
11	Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles	Cancer	2004	121
12	Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement	Cancer	2014	116
13	Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT	Annals of Oncology	2007	111
14	Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection	Leukemia	2012	98
15	Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia	Cancer	2012	97
16	TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial	Blood	2013	96
17	Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity	Haematologica	2006	95
18	Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma	Haematologica	2010	91
19	Immune-mediated neuropathies in myeloma patients treated with bortezomib	Clinical Neurophysiology	2008	88
20	Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy	Annals of Oncology	2006	85
21	Leukemic transformation of polycythemia vera	Cancer	2005	79
22	Clinical relevance of JAK2 (V617F) mutant allele burden	Haematologica	2009	78
23	Bortezomib-induced peripheral neuropathy in multiple myeloma: A comparison between previously treated and untreated patients	Leukemia Research	2010	75
24	Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution	Leukemia	2005	72
25	Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia	Haematologica	2003	68
26	Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone	Annals of Hematology	2004	64
27	Nongastric Marginal‐Zone B‐Cell MALT Lymphoma: Prognostic Value of Disease Dissemination	Oncologist	2006	63
28	Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients	Leukemia	2003	61
29	Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma	Cancer	2005	61
30	COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies	British Journal of Haematology	2021	56
31	A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective  and non-toxic treatment for advanced follicular  and mantle cell lymphoma	British Journal of Haematology	2002	54
32	DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features	Blood	2015	53
33	The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia clinical results in 46 patients	Cancer	1993	52
34	Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation as a Late Complication of Chronic Graft-versus-Host Disease	Transplantation	2006	51
35	Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders	Leukemia	2004	50
36	Risk of second cancers in Waldenström macroglobulinemia	Annals of Oncology	2012	50
37	Leukocytosis as an important risk factor for arterial thrombosis in WHO‐defined early/prefibrotic myelofibrosis: An international study of 264 patients	American Journal of Hematology	2012	49
38	Genetic and phenotypic attributes of splenic marginal zone lymphoma	Blood	2022	49
39	Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity	Haematologica	2000	49
40	HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry	Bone Marrow Transplantation	2009	48
41	Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease	European Journal of Haematology	2009	47
42	Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT	Annals of Oncology	2010	46
43	Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies	Oncotarget	2011	44
44	CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL	Blood	2010	44
45	Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma	Annals of Oncology	2008	40
46	FuseFISH: Robust Detection of Transcribed Gene Fusions in Single Cells	Cell Reports	2014	39
47	Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk	Supportive Care in Cancer	2019	38
48	Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis	British Journal of Haematology	2002	36
49	Rapid Response to High-Dose Steroids of Severe Bortezomib-Related Pulmonary Complication in Multiple Myeloma	Journal of Clinical Oncology	2007	36
50	Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea	Leukemia	2002	35

Profile

Scientometrics

Citing Bodies

Division of Hematology

Top Articles